Page 53 - RCPA

Notes to the Financial Statements
THE ROYAL COLLEGE OF PATHOLOGISTS OF AUSTRALASIA
ABN 52 000 173 231
NOTES TO THE FINANCIAL STATEMENTS FOR THE FINANCIAL YEAR ENDED 30 JUNE 2018
5. Profit (continued)
(b) Significant Revenues and Expenses
The following revenue and expenses are relevant in explaining the financial performance of the College:
2018 2017 $$
Included in revenue and other expenses per the Statement of Profit or Loss and Other Comprehensive Income are the following revenues and expenses resulting from specific grants received by the College. Grant revenue is recognised as expenses are incurred, any excess of Grant receipts over Grant expenses is recognised in the Statement of Financial
Position as Deferred Grant Income. Unexpended Grant income is returned to provider.
the Grant
-
- 43,657
622,903 622,903 12,998
- - -
350,543 350,543 112,154
4,867
4,867 23,197
134,310 134,310 2,565
19,691 19,691 -
Other Grants Revenues
Expenses
Deferred Grant Income
Grant - Standardisation of Pathology Information Terminology and Units (first & second grant) Revenues
Expenses
Deferred Grant Income
- - -
- - -
Grant – Standardisation of Pathology Information
Terminology and units (third grant)
Revenues 275
Expenses
Deferred Grant income
Grant – Pathology Workforce Change - National Cervical Screening Program
Revenues
Expenses
Deferred Grant Income
Grant – Health Genomics Stage 1 & 2 Revenue
Expenses
Deferred Grant Revenue
275 256,125
230,773 230,773 18,882
153,676 153,676 26,937
Grant – Structured Reporting of Cancer funding for an
additional protocol
Revenues - Expenses - Deferred Grant income 2,565
Grant - Structural Pathology Reporting of Cancer
Revenues - Expenses -
Deferred Grant Income
-
13
51
ANNUAL REPORT • 2017 - 2018